Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Current Deferred Revenue (2023 - 2025)

SANUWAVE Health (SNWV) has disclosed Current Deferred Revenue for 3 consecutive years, with $252000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Current Deferred Revenue rose 83.94% to $252000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $252000.0, a 83.94% increase, with the full-year FY2024 number at $193000.0, up 109.78% from a year prior.
  • Current Deferred Revenue was $252000.0 for Q3 2025 at SANUWAVE Health, up from $221000.0 in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $252000.0 in Q3 2025 to a low of $62000.0 in Q1 2023.
  • A 3-year average of $138363.6 and a median of $130000.0 in 2024 define the central range for Current Deferred Revenue.
  • Peak YoY movement for Current Deferred Revenue: surged 109.78% in 2024, then skyrocketed 70.0% in 2025.
  • SANUWAVE Health's Current Deferred Revenue stood at $92000.0 in 2023, then skyrocketed by 109.78% to $193000.0 in 2024, then skyrocketed by 30.57% to $252000.0 in 2025.
  • Per Business Quant, the three most recent readings for SNWV's Current Deferred Revenue are $252000.0 (Q3 2025), $221000.0 (Q2 2025), and $193000.0 (Q1 2025).